17
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Biopsy and Prognosis for Cutaneous Malignant Melanomas in Clinical Stage I

, &
Pages 141-144 | Received 14 Jun 1979, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

N. Balakrishnan & T. Feng. (2019) Destructive cure rate models under proportional odds and associated likelihood inference. Communications in Statistics: Case Studies, Data Analysis and Applications 5:2, pages 121-145.
Read now
Pei-Fang Su. (2017) Power and sample size calculation for the additive hazard model. Journal of Biopharmaceutical Statistics 27:4, pages 571-583.
Read now

Articles from other publishers (28)

Szilárd Nemes, Andreas Gustavsson & Alexandra Jauhiainen. (2022) Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators. Entropy 24:5, pages 713.
Crossref
Jorne Lionel Biccler, Martin Bøgsted, Stefan Van Aelst & Tim Verdonck. (2020) Outlier robust modeling of survival curves in the presence of potentially time-varying coefficients. Statistical Methods in Medical Research 29:9, pages 2683-2696.
Crossref
Andrea Arfé, Stefano Peluso & Pietro Muliere. (2019) Reinforced urns and the subdistribution beta‐Stacy process prior for competing risks analysis. Scandinavian Journal of Statistics 46:3, pages 706-734.
Crossref
Oswaldo Gressani & Philippe Lambert. (2018) Fast Bayesian inference using Laplace approximations in a flexible promotion time cure model based on P-splines. Computational Statistics & Data Analysis 124, pages 151-167.
Crossref
Joseph F. Sobanko, Justin J. Leitenberger, Neil A. Swanson & Ken K. Lee. 2011. Cancer of the Skin. Cancer of the Skin 434 442 .
Piotr Rutkowski, Marcin Zdzienicki, Zbigniew I. Nowecki & Alexander C. J. Van Akkooi. (2010) Surgery of Primary Melanomas. Cancers 2:2, pages 824-841.
Crossref
D. Sinha, M. B. McHenry, S. R. Lipsitz & M. Ghosh. (2009) Empirical Bayes estimation for additive hazards regression models. Biometrika 96:3, pages 545-558.
Crossref
R W Griffiths & J C Briggs. (1986) Incidence of locally metastatic(‘recurrent’) cutaneous malignant melanoma following conventional wide margin excisional surgery for invasive clinical stage I tumours: Importance of maximal primary tumour thickness. British Journal of Surgery 73:5, pages 349-353.
Crossref
Jonhan Ho, Robert T. Brodell & Stephen E. Helms. (2005) Saucerization biopsy of pigmented lesions. Clinics in Dermatology 23:6, pages 631-635.
Crossref
Neil A Swanson, Ken K Lee, Annalisa Gorman & Han N Lee. (2002) Biopsy techniques. Dermatologic Clinics 20:4, pages 677-680.
Crossref
C.R Rossi, M Foletto, A Vecchiato, S Alessio, N Menin & M Lise. (1997) Management of cutaneous melanoma M0: state of the art and trends. European Journal of Cancer 33:14, pages 2302-2312.
Crossref
Thomas G Salopek, Johnny Slade, Ashfaq A Marghoob, Darrell S Rigel, Alfred W Kopf, Robert S Bart & Robert J Friedman. (1995) Management of cutaneous malignant melanoma by dermatologists of the American Academy of Dermatology. I. Survey of biopsy practices of pigmented lesions suspected as melanoma. Journal of the American Academy of Dermatology 33:3, pages 441-450.
Crossref
Timothy M Johnson, John W SmithIIII, Bruce R Nelson & Alfred Chang. (1995) Current therapy for cutaneous melanoma. Journal of the American Academy of Dermatology 32:5, pages 689-707.
Crossref
H. Breuninger, S. Conrads, B. d’Hoedt, W. Stroebel & G. Rassner. 1995. Operative Dermatologie. Operative Dermatologie 233 238 .
Paul F. Mansfield, Jeffrey E. Lee & Charles M. Balch. (1994) Cutaneous melanoma: Current practice and surgical controversies. Current Problems in Surgery 31:4, pages 265-374.
Crossref
Michael Landthaler. 1993. Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie 155 160 .
Hans Holmström. (2006) Surgical management of primary melanoma. Seminars in Surgical Oncology 8:6, pages 366-369.
Crossref
W. Clark Lambert & Robert A. Schwartz. (1992) Metastasis. Journal of the American Academy of Dermatology 27:1, pages 131-133.
Crossref
Vincent C. Ho & Arthur J. Sober. (1990) Therapy for cutaneous melanoma: An update. Journal of the American Academy of Dermatology 22:2, pages 159-176.
Crossref
Michael Landthaler, Otto Braun-Falco, August Leitl, Birger Konz & Dieter Hölzel. (1989) Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer 64:8, pages 1612-1616.
Crossref
K. T. Drzewiecki, H. Poulsen, P. Vibe, C. Ladefoged & P. K. Andersen. 1988. Hautmelanome. Hautmelanome 416 421 .
ALFRED W. KOPF, BRUCE WELKOVICH, RENEE E. FRANKEL, EDWARD J. STOPPELMANN, ROBERT S. BART, GARY S. ROGERS, DARRELL S. RIGEL, ROBERT J. FRIEDMAN, MARCIA J. LEVENSTEIN, STEPHEN L. GUMPORT & PATRICK HENNESSEY. (2013) Thickness of Malignant Melanoma: Global Analysis of Related Factors. The Journal of Dermatologic Surgery and Oncology 13:4, pages 345-420.
Crossref
JOSIANE S. LEDERMAN & ARTHUR J. SOBER. (2013) Does Wide Excision as the Initial Diagnostic Procedure Improve Prognosis in Patients with Cutaneous Melanoma?. The Journal of Dermatologic Surgery and Oncology 12:7, pages 697-699.
Crossref
Josiane S. Lederman & Arthur J. Sober. (1985) Does biopsy type influence survival in clinical Stage I cutaneous melanoma?. Journal of the American Academy of Dermatology 13:6, pages 983-987.
Crossref
F.H.J. Rampen & E.P. van der Esch. (1985) Biopsy and survival of malignant melanoma. Journal of the American Academy of Dermatology 12:2, pages 385-388.
Crossref
Knud S�ndergaard & Geert Schou. (1985) Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. Virchows Archiv A Pathological Anatomy and Histopathology 408:2-3, pages 249-258.
Crossref
R. P. A. Müller & J. Petres. 1985. Fehlbildungen Nävi Melanome. Fehlbildungen Nävi Melanome 240 253 .
K. T. Drzewiecki & P. Kragh Andersen. (1982) Survival with malignant melanoma: A regression analysis of prognostic factors. Cancer 49:11, pages 2414-2419.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.